SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Teva Pharmaceuticals
TEVA 32.48-0.9%Jan 13 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LLLefty who wrote (152)2/11/1998 6:04:00 AM
From: Doug  Read Replies (1) of 340
 
Teva has lost its steam. Ares Serono another Israeli Company is now
trying to register REBIF, a beta iterferon treatment for M.S. This will be the 4th drug on the market. COPAZONE is a non beta drug that was targeted to get 1ok patients by 1997. Todate about half that number has been realised & marketing cost are soaring. The Company also lost 13M of domestic sales and that does not show any sign of recovery.

Until the Company shows some growth in earnings & sales ,it
is unlikely to breakout.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News